Navigation Links
Prescription Acne Treatment Manufacturing in the US Industry Market Research Report from IBISWorld Has Been Updated
Date:11/19/2013

Los Angeles, CA (PRWEB) November 19, 2013

Acne remains a common skin disorder experienced by teenagers and adolescents, affecting about 40 million to 50 million Americans, according to the American Academy of Dermatology. Due to increasing demand for acne treatments, the Prescription Acne Treatment Manufacturing industry has exhibited positive growth during the five years to 2013, and during the period, IBISWorld estimates that industry revenue has increased. Because acne-prone individuals consider treatment products a necessary expense, revenue continued to rise despite the recession, though growth did slow as consumers switched to more inexpensive products like over-the-counter (OTC) acne treatments. In addition, the increasing prevalence of adult-onset and persistent acne conditions has given rise to new, targeted products and an expanded consumer base, supporting revenue growth during the period. In 2013, with modest economic improvements giving way to greater disposable income growth, industry revenue is expected to increase.

According to IBISWorld Analyst Anna Son, “IBISWorld estimates that the top three players (Valeant Pharmaceuticals International Inc., Allergan Inc. and Galderma Laboratories LP) account for more than 20.0% of industry market share in 2013,” reflecting a low level of concentration. The remainder of the industry is characterized by a large number of small and medium-size businesses. Moreover, IBISWorld research indicates that companies employ only about 41 workers on average. In recent years, demand for prescription acne treatments has been mellow due to the rising use of OTC acne products, which are significantly less expensive and more easily accessible than their prescription counterparts. In recent years, more consumers have treated their acne with OTC products rather than seeing a specialist due to the difficulty of setting an appointment with a dermatologist, a general loss of health insurance coverage and a wide selection of OTC products. Nevertheless, in coming years, industry operators will be able to take advantage of new market opportunities stemming from the prevalence of adult onset acne.

“The outlook for the industry is promising,” says Son. During the five years to 2018, IBISWorld forecasts industry revenue to increase. The industry will benefit from improving economic conditions, as disposable income growth allows consumers to spend on higher-priced items. Furthermore, companies are expected to increasingly develop product lines with all-natural ingredients, given changing consumer preferences. Over the next five years, increasing private health insurance coverage will increasingly allow individuals access to prescription acne treatments, thus boosting industry demand. Still, the industry will continue to experience greater external competition from OTC acne products and laser treatments.

For more information, visit IBISWorld’s Prescription Acne Treatment Manufacturing in the US industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld industry Report Key Topics
Companies in the Prescription Acne Treatment Manufacturing industry are engaged in manufacturing prescription medications to control acne.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11342968.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Prescription Drug Addiction Rises Among Elderly—Novus Medical Detox Calls for Rx Drug Education
2. Tampa Drug Detox Introduces Updated Women’s Program for Rehabilitation from Prescription Drugs
3. The World Prescription Drug Market Report
4. New Best Drug Rehabilitation Video Features CEO Per Wickstrom Interviewing Dr. John R. Trotter II on Increasing Prescription Opiate Abuse
5. LOCKMED Develops New Product to Curb Prescription Drug Abuse
6. Diet Doc Hormone Diets & Weight Loss Plans Now Offers New Weight Loss Pills and Prescription Hormone Treatments to Enhance Low Fat Diets for Fast Fat Loss
7. Local Arizona Company Introduces New Patented Prescription Weight Loss Medicine
8. Diet Doc’s Prescription Hormone Diets & Weight Loss Plans Announces New Clean Eating Diet Plans to Slim the Waistline While Reducing the Risk for Colorectal Cancer
9. Diet Doc’s Prescription Hormone Diet Plans Now Offers More Affordable Diets, Making Weight Loss Inexpensive for Nearly Anyone
10. Diet Doc Hormone Diets & Weight Loss Plans Eliminate Belly Fat with Healthy Weight Loss Recipes and Diet Foods Enhanced by Prescription Hormone Treatments
11. Study: Access to health care increases prescription opioid availability and associated abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: